Intercontinental Stem Cell Corp. specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based analysis and beauty items. The business was very first to perfect the organic phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells can be immune-matched to thousands and thousands of men and women no matter of intercourse or racial qualifications, with minimal expectation of immune rejection after transplantation.

Seeking Alpha yesterday here released the adhering to report that includes ISCO: http://seekingalpha.com/report/1320381

The post titled “Curing Parkinson’s: The Different Technique â€" Is There Money To Be Manufactured?” provides an overview of the present treatments accessible, a number of new possibilities underneath improvement, and the all round value of Parkinson’s disease on our economy. ISCO took the spotlight with its parthenogenetic stem mobile-dependent approach, which lately produced good basic safety and efficacy information throughout placebo-controlled research. For far more information on these scientific studies, pay a visit to http://dtg.fm/a5Xh.

Ed Liston, author of the report, wrote, “Let me swiftly put a few positives for the ISCO treatment… It is a treatment of the fundamental disease and not mere mitigation of superficially observable symptoms… It utilizes cells from unfertilized eggs, consequently, there are no ethical issues related with the mobile source… The cells created making use of the company’s proprietary method are designed to be appropriate with the immune technique of the individual and hence, are not most likely to be rejected by the patient’s entire body on introduction.”

Almost 1 million Us citizens are at the moment afflicted by Parkinson’s ailment, which is triggered by the loss of life of dopamine-generating cells in the mind. The overall variety of new situations of Parkinson’s detected every year in the US is roughly sixty,000. In accordance to the Parkinson’s Ailment Basis, the price of the disease to the US financial system is approximately $twenty five billion a yr.

For much more info on Global Stem Mobile Corp. and its hpSC technological innovation, check out www.InternationalStemCell.com

Let us listen to your views: Intercontinental Stem Mobile Corp. Concept Board

This entry was posted on Friday, April 5th, 2013 at eleven:34 am and is filed below Global Stem Cell Corp. ISCO. You can stick to any responses to this entry by way of the RSS two. feed. You can leave a reaction, or trackback from your personal site.